公开(公告)号：US20220370392A1

公开(公告)日：2022-11-24

申请号：US17765156

申请日：2020-10-16

申请人： Aouatef Bellamine ,  Capsugel Belgium NV

发明人： Aouatef Bellamine ,  Stanislaw Glab ,  Shane Durkee

IPC分类号： A61K31/205 ,  A61K9/16 ,  A61K45/06 ,  A61K9/48 ,  A61P21/06

摘要： A method and composition for increasing muscle protein synthesis in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at an amino acid component including L-carnitine and a nitrogenous organic acid including creatine. In a particular embodiment, the creatine is in a solution with L-carnitine. The ratio of L-carnitine to creatine can be from about 10:1 to about 1:1. The protein building z composition can be administered in a monolithic enteric capsule.

公开(公告)号：US20220370393A1

公开(公告)日：2022-11-24

申请号：US17765173

申请日：2020-10-16

申请人： Capsugel Belgium NV

发明人： Aouatef Bellamine ,  Stanislaw Glab ,  Shane Durkee

IPC分类号： A61K31/205 ,  A61K9/48 ,  A61P21/06

摘要： A method and composition for increasing muscle protein synthesis in mammals is disclosed. In one embodiment, the mammals are administered a protein building composition comprising at an amino acid derivative including L-carnitine and a nitrogenous organic acid including creatine. In a particular embodiment, the creatine is in an acid resistant capsule delivery form. The ratio of L-carnitine to creatine can be from about 10:1 to about 1:1. The protein building composition can be administered in a monolithic enteric capsule.